Drug facts
BrandTrelstar (Triptorelin)
No generic triptorelin is approved; no NDA 020715 patent or exclusivity is listed in the Orange Book.
Trelstar was first approved by the FDA on 06/15/2000 under NDA 020715; the application holder is Verity Pharmaceuticals Inc.
Holder Verity Pharmaceuticals IncApplication NDA 020715Approved 06/15/2000
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No NDA 020715 patent listed in the Orange Book Orange Book
- Later patents, other products
- Trelstar (NDA 022437) 06/30/2029; Triptodur Kit 06/30/2029 Orange Book
02Competition
- Generics
- No generic approved Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Trelstar profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
04Product
- Application holder
- Verity Pharmaceuticals Inc Orange Book
- Application
- NDA 020715 Orange Book
- First approved
- 06/15/2000 Orange Book
- Dosage forms
- injectable
- Routes
- intramuscular
- Other brand names
- Triptodur Kit
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.